Publications for Finn Bengtsson
Co-author map based on ISI articles 2007-

Publications mentioned in social media 1 times*

Keywords

venlafaxine ven treatment sham serum rats pharmacokinetic pcs patients mirtazapine metabolites enantiomers drugs drug dose clinical citalopram chronic brain antidepressant

Journal Articles

Louise Karlsson, Henrik Green, Anna Lena Zackrisson, Finn Bengtsson, I Jakobsen Falk, Björn Carlsson, Johan Ahlner and Fredrik Kugelberg
  ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram
  International journal of legal medicine (Print), 2013, 127(3), 579-586.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Louise Karlsson, Björn Carlsson, Christoph Hiemke, Johan Ahlner, Finn Bengtsson, Ulrich Schmitt and Fredrik C. Kugelberg
  Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment
  European Neuropsychopharmacology, 2013, 23(11), 1636-1644.
   Fulltext  PDF  
 Web of Science® Times Cited: 2

Maria Kingbäck, Louise Karlsson, Anna-Lena Zackrisson, Martin Josefsson, Björn Carlsson, Finn Bengtsson, Johan Ahlner and Fredrik C Kugelberg
  Influence of CYP2D6 genotype on the disposition of the enantiomers of venlafaxine and its major metabolites in postmortem femoral blood
  Forensic Science International, 2012, 214(1-3), 124-134.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Louise Karlsson, Christoph Hiemke, Björn Carlsson, Martin Josefsson, Johan Ahlner, Finn Bengtsson, Ulrich Schmitt and Fredrik C Kugelberg
  Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model
  Psychopharmacology, 2011, 215(2), 367-377.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Maria Kingbäck, Björn Carlsson, Johan Ahlner, Finn Bengtsson and Fredrik Kugelberg
  Cytochrome P450-Dependent Disposition of the Enantiomers of Citalopram and Its Metabolites: In Vivo Studies in Sprague-Dawley and Dark Agouti Rats
  Chirality, 2011, 23(2), 172-177.
 Web of Science® Times Cited: 2

Maria D Cherma, Johan Ahlner, Finn Bengtsson and Per Gustafsson
  Antidepressant Drugs in Children and Adolescents Analytical and Demographic Data in a Naturalistic, Clinical Study
  JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31(1), 98-102.
 Web of Science® Times Cited: 3

Anders Olsson, Finn Bengtsson, A. Rosengren and P. Tornvall
  Patienten framför allt!
  Läkartidningen, 2010, 107(24), 1639.

Louise Karlsson, Ulrich Schmitt, Martin Josefsson, Björn Carlsson, Johan Ahlner, Finn Bengtsson, Fredrik C Kugelberg and Christoph Hiemke
  Blood-brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein
  European Neuropsychopharmacology, 2010, 20(9), 632-640.
   Fulltext  PDF  
 Web of Science® Times Cited: 19

Maria Kingbäck, Martin Josefsson, Louise Karlsson, Johan Ahlner, Finn Bengtsson, Fredrik C Kugelberg and Björn Carlsson
  Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction
  Journal of Pharmaceutical and Biomedical Analysis, 2010, 53(3), 583-590.
 Web of Science® Times Cited: 20

Anders Olsson, Finn Bengtsson, A. Rosengren and P. Tornvall
  Kolesterolhypotesen står sig
  Läkartidningen, 2010, 107(12), 831-836.

Björn Carlsson, A. Holmgren, Johan Ahlner and Finn Bengtsson
  Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19
  Journal of Analytical Toxicology, 2009, 33(2), 65-76.
 Web of Science® Times Cited: 3

Anna-Britta Lind, Margareta Reis, Finn Bengtsson, Michele Jonzier-Perey, Golay K. Powell, Johan Ahlner, P. Baumann and M.-L. Dahl
  Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour
  Clinical Pharmacokinetics, 2009, 48(1), 63-70.
 Web of Science® Times Cited: 17

Mikael Landen, Helena Erlandsson, Finn Bengtsson, Bjorn Andersch and Elias Eriksson
  Short Onset of Action of a Serotonin Reuptake Inhibitor When Used to Reduce Premenstrual Irritability
  NEUROPSYCHOPHARMACOLOGY, 2009, 34(3), 585-592.
 Web of Science® Times Cited: 11

Maria Dolores Chermá Yeste, Ulla-Britt Löfgren, Göran Almkvist, Claes Hallert and Finn Bengtsson
  Assessment of the prescription of antidepressant drugs in elderly nursing home patients
 
Altmetric usage: 1

  Journal of Clinical Psychopharmacology, 2008, 28(4), 424-431.
 Web of Science® Times Cited: 9

Maria Dolores Cherma Yeste, Margareta Reis, Staffan Hägg, Johan Ahlner and Finn Bengtsson
  Therapeutic Drug Monitoring of Ziprasidone in a Clinical Treatment Setting
  Therapeutic Drug Monitoring, 2008, 30(6), 682-688.
 Web of Science® Times Cited: 8

Margareta Reis, Maria Dolores Cherma Yeste, Björn Carlsson and Finn Bengtsson
  Therapeutic Drug Monitoring of Escitalopram in an outpatient setting
  Therapeutic Drug Monitoring, 2007, 29(6), 758-766.
 Web of Science® Times Cited: 17

Knorring L. von, A.-C. Akerblad, Finn Bengtsson, A. Carlsson and L. Ekselius
  Cost of depression: effect of adherence and treatment response
  European psychiatry, 2006, 21(6), 349-354.
 Web of Science® Times Cited: 18

AA Zaitoun, G Apelqvist, H Al-Mardini, T Gray, Finn Bengtsson and CO Record
  Quantitative studies of liver atrophy after portacaval shunt in the rat
  Journal of Surgical Research, 2006, 131(2), 225-232.
 Web of Science® Times Cited: 7

Fredrik Kugelberg, Gustav Apelqvist, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Sustained citalopram treatment in experimental hepatic encephalopathy: Effects on entrainment to the light-dark cycle and melatonin
  Basic & Clinical Pharmacology & Toxicology, 2006, 99(1), 80-88.
 Web of Science® Times Cited: 3

Jan Wålinder, J Prochazka, A Odén, Ingemar Sjödin, ML Dahl, Johan Ahlner and Finn Bengtsson
  Mirtazapine naturalistic depression study (in Sweden) - MINDS(S): Clinical efficacy and safety
  Human Psychopharmacology: Clinical and Experimental, 2006, 21(3), 151-158.
 Web of Science® Times Cited: 4

AC Åkerblad, Finn Bengtsson, L von Knorring and L Ekselius
  Response, remission and relapse in relation to adherence in primary care treatment of depression: A 2-year outcome study
  International Clinical Psychopharmacology, 2006, 21(2), 117-124.
 Web of Science® Times Cited: 21

Finn Bengtsson
  Fler arbetsgivare i vården
  Östgöta Correspondenten, 2005, 24 augusti, .

Finn Bengtsson
  Hur är det ställt med demokratin?
  Östgöta Correspondenten, 2005, 23 mars, .

Finn Bengtsson
  Arrogant maktspråk från landstingsledningen
  Östgöta Correspondenten, 2005, 11 mars, .

Margareta Reis, Jiri Prochazka, Ad Sitsen, Johan Ahlner and Finn Bengtsson
  Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: A 6-month therapeutic drug monitoring study
  Therapeutic Drug Monitoring, 2005, 27(4), 469-477.
 Web of Science® Times Cited: 19

Fredrik Kugelberg, G Apelqvist, C Wikell and Finn Bengtsson
  Open-field behavioural alterations in liver-impaired and sham-operated rats after acute exposure to the antidepressant venlafaxine
  Basic & Clinical Pharmacology & Toxicology, 2005, 97(3), 155-161.
 Web of Science® Times Cited: 1

Björn Isaksson, Lars-Håkan Thorell, Finn Bengtsson, I Rosén and I Jeppsson
  Hepatic encephalopathy verified by psychometric testing and EEG in cirrhotic patients: Effects of mesocaval interposition shunt or sclerotherapy
  HPB, 2005, 7(1), 65-72.

Finn Bengtsson
  Therapeutic drug monitoring of psychotropic drugs - TDM "Nouveau"
  Therapeutic Drug Monitoring, 2004, 26(2), 145-151.
 Web of Science® Times Cited: 32

M Olsson, K Annerbrink, Finn Bengtsson, J Hedner and E Eriksson
  Paroxetine influences respiration in rats: Implications for the treatment of panic disorder
  European Neuropsychopharmacology, 2004, 14(1), 29-37.
 Web of Science® Times Cited: 11

Fredrik Kugelberg, Henrik Druid, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in rats
  Journal of Analytical Toxicology, 2004, 28(8), 631-637.
 Web of Science® Times Cited: 10

Margareta Reis, Anna Åberg-Wistedt, Hans Ågren, Ann-Charlotte Åkerblad and Finn Bengtsson
  Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
  Journal of Affective Disorders, 2004, 82(3), 443-446.
 Web of Science® Times Cited: 15

Margareta Reis, Anna Åberg-Wistedt, Hans Ågren, Peter Höglund, Ann-Charlotte Åkerblad and Finn Bengtsson
  Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
  Human Psychopharmacology: Clinical and Experimental, 2004, 19(5), 283-291.
 Web of Science® Times Cited: 17

AC Åkerblad, Finn Bengtsson, L Ekselius and L von Knorring
  Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners
  International Clinical Psychopharmacology, 2003, 18(6), 347-354.
 Web of Science® Times Cited: 22

Daniel Öhman, Maria Dolores Cherma Yeste, Björn Norlander and Finn Bengtsson
  Determination of serum reboxetine enantiomers in patients on chronic medication with racemic reboxetine
  Therapeutic Drug Monitoring, 2003, 25(2), 174-182.
 Web of Science® Times Cited: 15

Margareta Reis, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992-1997
  Therapeutic Drug Monitoring, 2003, 25(2), 183-191.
 Web of Science® Times Cited: 35

Fredrik Kugelberg, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Stereoselective single-dose kinetics of citalopram and its metabolites in rats
  Chirality, 2003, 15(7), 622-629.
 Web of Science® Times Cited: 22

Elisabeth Skogh, Margareta Reis, Marja-Liisa Dahl, Jöns Lundmark and Finn Bengtsson
  Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 518-526.
 Web of Science® Times Cited: 59

Margareta Reis, Jöns Lundmark, Henrik Björk and Finn Bengtsson
  Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting
  Therapeutic Drug Monitoring, 2002, 24(4), 545-553.
 Web of Science® Times Cited: 37

Cecilia Wikell, Gustav Apelqvist, Stefan Hjorth, J Kullingsjö, PB Bergqvist and Finn Bengtsson
  Effects on drug disposition, brain monoamines and behavior after chronic treatment with the antidepressant venlafaxine in rats with experimental hepatic encephalopathy
  European Neuropsychopharmacology, 2002, 12(4), 327-336.
 Web of Science® Times Cited: 8

Fredrik C. Kugelberg, Gustav Apelqvist and Finn Bengtsson
  Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in rats
  Pharmacology and Toxicology, 2002, 90(6), 303-310.
 Web of Science® Times Cited: 15

Jöns Lundmark, Tove Gunnarsson and Finn Bengtsson
  A possible interaction between lithium and rofecoxib [1]
  British Journal of Clinical Pharmacology, 2002, 53(4), 403-404.
 Web of Science® Times Cited: 10

Daniel Öhman, Björn Norlander, Curt Peterson and Finn Bengtsson
  Simultaneous determination of reboxetine and O-desethylreboxetine enantiomers using enantioselective reversed-phase high-performance liquid chromatography
  Journal of Chromatography A, 2002, 947(2), 247-254.
 Web of Science® Times Cited: 22

Margareta Reis, Gunilla Olsson, Björn Carlsson, Jöns Lundmark, Marja-Liisa Dahl, Jan Wålinder, Johan Ahlner and Finn Bengtsson
  Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
  Journal of Clinical Psychopharmacology, 2002, 22(4), 406-413.
 Web of Science® Times Cited: 10

C Wikell, CB Eap, M Josefsson, G Apelqvist, Johan Ahlner, P Baumann and Finn Bengtsson
  Disposition of venlafaxine enantiomers in rats with hepatic encephalopathy after chronic drug treatment
  Chirality, 2002, 14(4), 347-350.
 Web of Science® Times Cited: 3

C Wikell, S Hjorth, G Apelqvist, J Kullingsjö, Jöns Lundmark, PBF Bergqvist and Finn Bengtsson
  Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings
  Archives of Pharmacology, 2001, 363, 448-455.
 Web of Science® Times Cited: 15

M Humble, S Bejerot, PB Bergqvist and Finn Bengtsson
  Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder?
  Biological Psychiatry, 2001, 49, 360-368.
 Web of Science® Times Cited: 12

Jöns Lundmark, Margareta Reis and Finn Bengtsson
  Serum concentrations of fluoxetine in the clinical treatment setting
  Therapeutic Drug Monitoring, 2001, 23(2), 139-147.
 Web of Science® Times Cited: 34

Love Linner, Hanna Endersz, Daniel Öhman, Finn Bengtsson, Martin Schalling and Torgny Svensson
  Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex
  Journal of Pharmacology and Experimental Therapeutics, 2001, 297(2), 540-546.
 Web of Science® Times Cited: 74

Daniel Öhman, Björn Norlander, Curt Peterson and Finn Bengtsson
  Bioanalysis of racemic reboxetine and its desethylated metabolite in a therapeutic drug monitoring setting using solid phase extraction and HPLC
  Therapeutic Drug Monitoring, 2001, 23(1), 27-34.
 Web of Science® Times Cited: 25

Cecilia Wikell, Fredrik Kugelberg, Stephan Hjorth, Gustav Apelqvist and Finn Bengtsson
  Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy
  Clinical neuropharmacology, 2001, 24(6), 324-333.
 Web of Science® Times Cited: 3

Fredrik Kugelberg, Gustav Apelqvist, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats
  British Journal of Pharmacology, 2001, 132(8), 1683-1690.
 Web of Science® Times Cited: 29

Björn Carlsson, Gunilla Olsson, Margareta Reis, Jan Wålinder, Conny Nordin, Jöns Lundmark, M. G. Scordo, M-L. Dahl, Finn Bengtsson and Johan Ahlner
  Enantioselective Analysis of Citalopram and Metabolites in Adolescents
  Therapeutic drug monitoring, 2001, 23(6), 658-664.
 Web of Science® Times Cited: 24

Jöns Lundmark, Finn Bengtsson, Conny Nordin, Margareta Reis and Jan Wålinder
  Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients
  Acta Psychiatrica Scandinavica, 2000, 101(5), 354-359.
 Web of Science® Times Cited: 60

Jöns Lundmark, Margareta Reis and Finn Bengtsson
  Therapeutic drug monitoring of sertraline: Variability factors as displayed in a clinical setting
  Therapeutic Drug Monitoring, 2000, 22(4), 446-454.
 Web of Science® Times Cited: 36

Lisa Ekselius, Finn Bengtsson and Lars von Knorring
  Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality.
  International Clinical Psychopharmacology, 2000, 15, 273-278.
 Web of Science® Times Cited: 7

Anna Åberg-Wistedt, Hans Ågren, Lisa Ekselius, Finn Bengtsson and AC Åkerblad
  Sertraline versus paroxetine in major depression: Clinical outcome after six months of continuous therapy
  Journal of Clinical Psychopharmacology, 2000, 20(6), 645-652.
 Web of Science® Times Cited: 63

C Wikell, G Apelqvist, Björn Carlsson, S Hjorth, P B F Bergqvist, Fredrik Kugelberg, Johan Ahlner and Finn Bengtsson
  Pharmacokinetic and pharmacodynamic responses to chronic admininstration of the selective serotonin reuptake inhibitor citalopram in rats.
  Clinical neuropharmacology, 2000, 22, 327-336.

G Apelqvist, C Wikell, Björn Carlsson, S Hjorth, P B F Bergqvist, Johan Ahlner and Finn Bengtsson
  Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy
  Clinical neuropharmacology, 2000, 23(6), 304-317.
 Web of Science® Times Cited: 7

Finn Bengtsson
  Brain tryptophan/serotonin perturbations in metabolic encephalopathy and the hazards involved in the use of psychoactive drugs
  Advances in Experimental Medicine and Biology, 1999, 467, 139-154.

Elisabeth Skogh, Finn Bengtsson and Conny Nordin
  Could discontinuing smoking be hazardous for patients administered clozapine medication? A case report.
  Therapeutic Drug Monitoring, 1999, 21, 580-582.

G Apelqvist, C. Wikell, B Hindfeldt, PBF Bergqvist, G. Andersson and Finn Bengtsson
  Altered open-field behavior in experimental chronic hepatic encephalopathy after single venlafaxine and citalopram challenges.
  Psychopharmacology, 1999, 143, 408-416.

P. Bergkvist, R Carpenedo, G Apelqvist, F Moroni and Finn Bengtsson
  Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan.
  Pharmacology and Toxicology, 1999, 85, 138-143.

Chapters in Books

Finn Bengtsson
  Postmarketing surveillance studier av antidepressiva via läkemedelsanalyser. I.
  Aktuell neuropsykiatrisk forskning, Linköpings universitet, 2001, 66-74.


Finn Bengtsson
  "Neurologi. Diagnostisk handledning" av Bengt Hindfelt
  Neurologi : diagnostisk handledning, Linköpings universitet, 2001, -104.


Conference Articles

U Schmitt, Y Schoenfelder, L Karlsson, F C Kugelberg, Finn Bengtsson and C Hiemke
  Forced swim-test-related antidepressant effects depend on P-glycoprotein expression in the Blood-Brain-Barrier
  in PHARMACOPSYCHIATRY, ISSN 0176-3679, vol 42, issue 5, 2009.


Louise Karlsson, Maria Kingbäck, M Josefsson, Björn Carlsson, Johan Ahlner, U Schmidt, Fredrik Kugelberg, Ch Hiemke and Finn Bengtsson
  Penetration of the enantiomers of venlafaxine and its metabolites into the brain in mice lacking P-glycoprotein (mdr1ab)
  50th CINP; Congress, Collegium Internationale Neuro-Psychopharmacologicum München, 2008.


Maria Kingbäck, M Josefsson, Fredrik Kugelberg, Finn Bengtsson, Johan Ahlner and Björn Carlsson
  Stereoselective analysis of venlafaxine and its three major metabolites by liquid chromatography with electrospray tandem mass spectrometry
  50th CINP; Congress, Collegium Internationale Neuro-Psychopharmacologicum München, 2008.


Maria Dolores Cherma Yeste, Björn Carlsson, Ulla-Britt Löfgren, Göran Almkvist, Claes Hallert and Finn Bengtsson
  Prescription of antidepressant drugs in elderly nursing home patients.: A Follow-up investigation with focus on enantioselective citalopram analysis
  10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, 2007.


Björn Carlsson, Anita Holmgren, Johan Ahlner and Finn Bengtsson
  Citalopram and escitalopram in postmortem blood: Confirmation of screening results from autopsy cases with enantioselective analysis.
  Nordisk kollokvium Rättstoxikologi.,2007, 2007.


Finn Bengtsson and Fredrik Kugelberg
  Fate of psychotropic drugs at the blood-brain-barrier and the brain: pharmacokinetic, pharmacodynamic and clinical consequences
  Association of European Psychiatrists AEP Congress,2005, 2005.


Finn Bengtsson and Johan Ahlner
  Insights in stereopharmacology in modern antidepressant treatment
  Association of European Psychiatrists AEP Congress,2005, 2005.


Maria Dolores Cherma Yeste, Björn Carlsson and Finn Bengtsson
  Achiral determination of venlafaxine and metabolities in human plasma by high-performance liquid chromatography and on-line automated sample preparation using restricted access material. Outcome from an naturalistic setting
  8th International Congress of Therapeutic Drug Monitoring and Clinical Toxikology,2004, 2004.


Ulrika Rosenqvist, M Tornqvist and Finn Bengtsson
  An interaction between sertraline and carbamazepine which resluted in sub-therapeutic concentrations of sertraline and N-desmethylsertraline in serum
  Therapeutic Drug Monitoring, 2003.


Fredrik Kugelberg, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Disposition of the enantiomers of citalopram and its demethylated metabolites in rats
  Therapeutic Drug Monitoring, 2003.


U Rosenqvist, M Törnqvist and Finn Bengtsson
  Therapeutic Drug Monitoring: An interaction between sertraline ana Carbamazepine which resulted in sub-therapeutic concentrations of sertraline and N-desmethyl.
  Skriv in din egen text för ej reg. tidskrift etc.,2003, 2003.


Fredrik Kugelberg, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Ther Drug Monit: Disposition of the enantiomers of citalopram and its demethlated metabolites in rats.
  Skriv in din egen text för ej reg. tidskrift etc.,2003, 2003.


Fredrik Kugelberg, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Disposition of the enantiomers of citalipram and its demethylated metabolites in rats.
  Ther Drug Monit,2003, 2003.


Finn Bengtsson
  260 therapeutic drug monitorings (TDM) in relation to compliance and co-medication in psychiatric treatment
  European psychiatry, 2002.


Björn Carlsson, Maria Dolores Cherma Yeste and Finn Bengtsson
  Achiral determination of venlafaxine and metabolites, in human plasma, by high-performance liquid chromatography and on-line automated sample preparation using restricted access material.
  18th European Workshop on Drug Metabolism, Valencia, Spain,2002, 2002.


Fredrik Kugelberg, Björn Carlsson, Björn Ahlner and Finn Bengtsson
  Pharmacokinetics of citalopram enantiomers after chronic and acute administration of racemate in rats.
  Nord J Psychiatry,2002, 2002.


Daniel Öhman, Curt Peterson and Finn Bengtsson
  Development of a TDM-Method for determination of the neuroleptic compound Ziprasidone and its S-methylated main metabolite.
  Pharmacol Toxicol,2001, 2001.


Fredrik Kugelberg, Gustav Apelqvist, Björn Carlsson, Johan Ahlner and Finn Bengtsson
  Effects of citalopram treatment on enantiomeric pharmacokinetic outcome and behaviour in rats.
  Pharmacology and Toxicology,2001, 2001.


Finn Bengtsson
  From receptor pharmacology to clinical prescription: Antidepressants
  European psychiatry, 2000.


Ph.D. Theses

Louise Karlsson
  P-glycoprotein and chiral antidepressant drugs: Pharmacokinetic, pharmacogenetic and toxicological aspects
  2012.


  Fulltext PDF

Maria Kingbäck
  Genetic influence on enantiomeric drug disposition: Focus on venlafaxine and citalopram
  2011.


  Fulltext PDF

Margareta Reis
  Pharmacokinetics of antidepressant drugs: naturalistic and clinical trials
  2003.


Jöns Lundmark
  Clinical and Pharmacological Aspects of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression in Old Age
  2000.


Reports

Finn Bengtsson
  Klinisk farmakokinetik vid antidepressiv läkemedelsbehandling. Inom ramen för projektgruppen för depressionsbehandling.
  2004.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.